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Introduction
Diabetic cardiomyopathy (DCM), a common complication of diabetes, represents the leading cause of morbidity and mortality among diabetic patients [1] . It is widely accepted that DCM is characterized by a set of structural and functional abnormalities in the heart of diabetics, including impaired diastolic and systolic contractility, cardiomyocyte hypertrophy and apoptosis, and myocardial fibrosis [2] . Of note, the impaired mitochondrial viability is essentially involved in the complex pathophysiological mechanisms of DCM [3, 4] , which can be critically regulated by peroxisome proliferator-activated receptor γ coactivator-1α (PGC-1α) [5, 6] . Despite the awareness of diabetes as a risk factor for heart failure, there is currently no specific clinical interventions for DCM or diabetes-associated heart failure [7, 8] .
Exercise training represents nowadays a useful nonpharmacological strategy for the treatment of cardiovascular diseases. The cardioprotective effect of exercise is not only associated with reduced cardiovascular risk factors, but also linked to improved antioxidant capacity and mitochondrial viability and activated physiological cardiac growth that is mediated by distinct cellular and molecular mechanisms from those for pathological hypertrophy [9, 10] . Several molecular signaling, such as PGC-1α and Akt, have been known to be crucial in mediating cardioprotective effects of exercise [11] . The benefit of exercise on the prevention and treatment of diabetes and its associated cardiac dysfunction has increasingly been reported [12] [13] [14] [15] . It has been shown in animal models that exercise could prevent ventricular remodeling, attenuate derangement of glucose and lipid metabolism, and improve mitochondrial function and antioxidant capacity, thus leading to ameliorated cardiac performance in the early stage of DCM [16] [17] [18] [19] [20] [21] [22] [23] . However, little is known about the effect of exercise on the late stage of DCM at an advanced age.
The aim of the study was to evaluate the potential of exercise on the structural and functional changes of diabetic hearts, and in particular, to further investigate the effect of exercise on mitochondrial biogenesis in the late stage of DCM at an advanced age by using a transgenic db/db mouse model. Here we show that exercise preserves cardiac function, prevents myocardial apoptosis and fibrosis, and improves mitochondrial biogenesis in the late stage of DCM, accompanied by an activation of PGC-1α and Akt signaling.
Materials and Methods

Animals and exercise training
Seven-week old male C57BL/6 wild-type mice and db/db mice were obtained from Model Animal Research Center of Nanjing University, maintained in specific pathogen-free (SPF) conditions under a 12h-light-12h-dark cycle, and fed ad libitum on a standard rodent diet. Mice were randomized into four groups: (1) sedentary wild-type mice (sedentary control, SC); (2) exercised wild-type mice (exercised control, EC); (3) sedentary db/db mice (SD); and (4) exercised db/db mice (ED). For mice engaged in a running program, the training course was carried out for 15 weeks at speed of 10 m/min for 1 hour running per day using a specialized designed mice treadmill. At the end of the study, ejection fraction (EF%) and fractional shortening (FS%) were measured using echocardiography. Mice aged 22 weeks were then sacrificed followed by examination of body weight and heart weight. This study was approved by the ethical committees of the Nanjing Medical University and all animal experiments were conducted under the guidelines on humane use and care of laboratory animals for biomedical research published by National Institutes of Health (No. 85-23, revised 1996) .
TUNEL assay
Heart tissues were harvested, embedded with paraffin, and sectioned into 4 μm slides. Apoptotic assay was carried out by TdT-mediated dUTP nick end labeling (TUNEL) reaction using in situ cell death detection Kit (cat. 11684817910, Roche).
Masson's trichrome staining
Masson's trichrome staining was used to detect collagen distribution. Heart sections were prepared as described in TUNEL assay. Masson's trichrome staining was performed according to instructions. Images were taken under light microscopy at 400x magnification for analysis.
Western blot analysis
Heart tissues were lysed in RIPA buffer (P0013C, Beyondtime) containing 1 mM PMSF (ST505, Beyondtime). Total protein of 30 µg was subjected to electrophorese on 12%-6% SDS-Page gels and transferred to PVDF membranes. Antibodies against Bax (1:1000; cat.2772, Cell Signaling Technology), Bcl-2 (1:1000; cat.2876, Cell Signaling Technology), PGC-1α (1:1000, cat. NBP1-04676, NOVUS), p-Akt
473
(1:1000; cat.4060, Cell Signaling Technology), and total Akt (1:1000; cat.4685, Cell Signaling Technology) were used as primary antibodies. Mouse or rabbit IgG antibodies coupled to horseradish peroxidase (HRP) were used as secondary antibodies. Actin (1:1000; cat.4967, Cell Signaling Technology) was used as loading control. An enhanced chemiluminescence (ECL) system was used for detection of protein bands.
Quantitative real time-PCR (qRT-PCR)
Total RNA of heart tissues was isolated using TRIZOL RNA extraction kit (Invitrogen). 400 ng of RNA was subjected to reverse transcription-PCR with iScript TM cDNA Synthesis Kit (cat.170-8891, Biorad) according to the instruction. Quantitative RT-PCR was performed with PCR primers listed in Table 1 . SYBR-Green supermix Kit (cat. 170-8882, Bio-rad) was employed to detect mRNA levels of these genes. All reactions were repeated 3 times and GAPDH was used to normalize target genes.
Transmission electron microscopy
The heart was fixed in 2.5% glutaraldehyde for 1 h, treated with 1% osmium tetroxide, and then dehydrated and embedded in Durcupan. Samples were then sectioned into 60 nm and mounted on Cu-grids, contrasted with uranyl acetate and lead citrate, and finally examined by electron microscopy. Images were taken at 30000x magnification for analysis.
Statistical analysis
All data were presented as mean ± SEM. One-way ANOVA was conducted to evaluate the one-way layout data. If a significant difference was observed, Bonferroni's post-hoc test was conducted to identify groups with significant differences. The relative mRNA levels were calculated using the 2 -ΔΔCt method. All analyses were performed using SPSS 19.0. Differences were considered significant with p<0.05. 
Results
Effects of exercise on experimental parameters
Experimental parameters of sedentary and exercised wild-type and db/db mice were shown in Table 2 . Body weight was not significantly different between SC and EC group, while exercise induced a significant increase of heart weight in EC group compared to SC group. Body weight was markedly greater for db/db mice (SD group) compared to wild-type mice, while exercise significantly reduced body weight gain in exercised db/db mice (ED group). Meanwhile, the impaired ejection fraction (EF) and fractional shortening (FS) for db/db mice were significantly restored by exercise in ED group.
Exercise prevents diabetes-induced cardiomyocyte apoptosis and myocardial fibrosis
Diabetes-induced cardiomyocyte apoptosis and myocardial fibrosis are typical features of DCM. Tunel assay showed increased cardiomyocyte apoptosis in diabetic hearts compared to normal hearts, which was significantly reduced by exercise for ED group (Fig.  1A) . The increased ratio of Bax/Bcl-2 at protein level in diabetic hearts was reversed by exercise training (Fig. 1B and C) . Furthermore, Masson's trichrome staining showed slightly myocardial fibrosis in db/db mice, which was attenuated by exercise for ED group (Fig. 2A) . The increased mRNA levels of collagen I and III in diabetic hearts were also reversed by exercise (Fig. 2B) . Exercise alone exerted no significant effect on cardiomyocyte apoptosis or myocardial fibrosis compared to normal hearts ( Fig. 1 and 2 ).
Exercise preserves mitochondrial biogenesis in diabetic hearts
The defective mitochondrial biogenesis critically contributes to the development of DCM [24, 25] . The expressions of 16sRNA, ND1, ND6 and CYTB encoded by mtDNA, as well as the genes involved in mtDNA replication such as single strand DNA binding protein 1 (SSBP1), TWINKLE and TOP1MT, were downregulated in diabetic hearts (Fig. 3A and B) . These impairments in mtDNA transcription and replication were however significantly restored by exercise in db/db mice ( Fig. 3A and B) . Meanwhile, we detected a remarkable reduction in mtDNA content (normalized by nDNA) in diabetic hearts, which was reversed by exercise (Fig. 3C) . Exercise also induced elevated mRNA levels of ND6 and CYTB (Fig.  3A) and an increase in mtDNA content (Fig. 3C ) in wild-type mice as compared to SC group. Furthermore, we performed electron microscopy which showed that SD group demonstrated damaged mitochondrial integrity in diabetic hearts, while exercise preserved the mitochondrial ultrastructure for ED group (Fig. 3D) .
Exercise activates PGC-1α and Akt signalings in diabetic hearts
As PGC-1α is a master regulator of mitochondrial metabolism [5] , we further investigated the effect of exercise on PGC-1α and its downstream transcription factors in diabetic hearts. Exercise upregulated NRF1 and TFB2M mRNA levels in wild-type mice (Fig. 4A) . Furthermore, the mRNA levels of PGC-1α, NRF1, TFAM, and TFB2M (known as the partner of TFAM) were downregulated in diabetic hearts, while exercise significantly upregulated these molecules involved in PGC-1α signaling pathway (Fig. 4A) . Although the protein level of PGC-1α was not changed in diabetic hearts, it was significantly upregulated by exercise in db/db mice ( Fig. 4B and C) . Akt, a serine/threonine kinase, is a well-known molecule contributing to exercise-induced cardioprotection [26] . While diabetes-associated insulin resistance contributes to decreased activation of Akt [24] . Here, we show that db/db mice displayed a significant inhibition of Akt phosphorylation in the heart, which was markedly reversed by exercise training (Fig. 4B and C) . Thus, the cardioprotective effect of exercise in the late stage of DCM is accompanied by an activation of PGC-1α and Akt signaling.
Discussion
Although exercise has been confirmed as an adjuvant therapy for diabetes and its associated cardiac dysfunction, the pathophysiological and molecular mechanisms underlying the beneficial effect of exercise in the late stage of DCM are poorly understood. The present study shows that long-term moderate intensity exercise prevents myocardial apoptosis and fibrosis, ameliorates mitochondrial biogenesis, and preserves cardiac function in advanced DCM, accompanied by an activation of PGC-1α and Akt signaling.
Diabetes-associated myocardial apoptosis and fibrotic replacement account for a loss of cardiac function [2] . Concomitant with previous studies [9] , long-term moderate intensity exercise leads to physiological cardiac growth with increased EF and FS indicating an improved cardiac function, while no significant cardiomyocyte apoptosis or myocardial fibrosis has been found in exercised wild-type mice compared to sedentary wild-type mice. Importantly, exercise exerts beneficial effects to prevent myocardial apoptosis and fibrosis in diabetic hearts. In fact, exercise has been shown to diminish mitochondria-mediated cardiomyocyte apoptosis and to reduce myocardial fibrosis in the aging heart [27, 28] . Here, we speculate that the improved cardiac function in aging diabetic hearts is at least in part attributable to reduced myocardial apoptosis and fibrosis. There has been increasing evidence indicating that impaired mitochondrial biogenesis attributes to cardiac dysfunction in diabetic states [2, 3, 24, 25, 29] . The present study shows defective mtDNA replication and impaired mitochondrial biogenesis in the hearts of db/ db mice, which can be abolished by exercise training. PGC-1α, a transcriptional coactivator, plays key roles in the regulation of myocardial energy metabolism [5, 6] and participates in the control of mitochondrial biogenesis and function through regulating its downstream transcription factors such as NRF and TFAM [30, 31] . It is known that the expression of PGC-1α can be induced with exercise activity [5, 32, 33] , while downregulated in pathological cardiac hypertrophy and heart failure [34] [35] [36] . Also, the PGC-1α can be regulated with aging process and aging-associated diseases [37] . However, the defective regulation of PGC-1α in diabetes is contradictory, since PGC-1α expression has been found to be either upregulated or unchanged in animal models of diabetes, closely related to the age and the stage of diabetes in mice [37] [38] [39] [40] . Here we demonstrate reduced expressions of PGC-1α at mRNA level and its downstream transcription factors such as NRF1, TFAM and TFB2M in diabetic hearts. Of note, the stage of the disease and the age of db/db mice were different between our study (late stage at old age) and previous ones (early stage at young age). Thus, although PGC-1α has been reported to be upregulated in diabetes, the downregulation of PGC-1α is probably inevitable with the progress of DCM into advanced stage. More importantly, exercise significantly activates the PGC-1α signaling in the hearts of db/db mice. These data suggest that the beneficial effect of exercise might be mediated by the activation of PGC-1α, although the direct relationship between PGC-1α activation and the impact of exercise on mitochondrial biogenesis in DCM remains to be further clarified. Noteworthy, it has previously been reported that although PGC-1α promoted cardiac mitochondrial biogenesis, the expansion of mitochondria density could lead to sarcomeric disruption and impaired cardiac contractile function [41] . Thus, PGC-1α regulation and mitochondrial biogenesis need to be discreetly controlled to exert beneficial effects on cardiac function. Last but not least, given that glucose and lipid metabolic disorders as well as insulin resistance also contribute to diabetic status and impaired cardiac function in DCM which can be regulated by PGC-1α [4, 24] , it would be of great interest to look into the regulatory effect of PGC-1α on glucose and lipid metabolism by measurements of serum glucose, c-peptide, insulin, and lipid levels in the future work.
Akt has been known to be required for exercise-induced cardiac physiological remodeling and to protect the heart from pressure overload and ischemia-reperfusion injury [42, 43] . Whereas the hyperglycemia and insulin resistance are associated with an inactivation of Akt signaling leading to the impairment of glucose metabolism [24, 44] . Our findings demonstrate that diabetes-associated inhibition of Akt phosphorylation could be significantly reversed by exercise training, suggesting that exercise might also prevent cardiac injury in DCM via regulating Akt. In fact, it has previously been shown that the phosphorylation of Akt results in the upregulation of glucose transporter (GLUT)-4 in cardiomyocytes, thus facilitating glucose metabolism in diabetic hearts [4, 45] . Knowing that Akt appears to be crucial in diabetes, further research is required to determine the functional influence of exerciseinduced Akt activation in the treatment of DCM.
In summary, the present study shows the beneficial effect of long-term exercise on the treatment of DCM at an advanced disease stage, via reduced myocardial apoptosis and fibrosis as well as improved mitochondrial biogenesis. The upregulated PGC-1α and Akt signaling in the hearts of exercised db/db mice might be considered as promising molecular targets for the development of novel pharmacotherapy for DCM.
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